Gene expression profiling of treatment response to anti-TNF-alpha therapy in rheumatoid arthritis

Gene expression profiling of treatment response to anti-TNF-alpha therapy in rheumatoid arthritis

Bibliographic Details
Main Authors:	Meisel, C, Newton, J, Harney, S, Wordsworth, B, Brown, M
Format:	Conference item
Published:	2004

Similar Items

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
by: Maini, R, et al.
Published: (1993)

Non-DRB1 MHC genes associated with rheumatoid arthritis are also differentially expressed
by: Harney, S, et al.
Published: (2005)

Molecular genetics of rheumatoid arthritis.
by: Harney, S, et al.
Published: (2003)

Cerebral processing of pain in rheumatoid arthritis patients treated with antiTNF-alpha
by: Wartolowska, K, et al.
Published: (2008)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
by: Maini, R, et al.
Published: (1994)

Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.
by: Taylor, P, et al.
Published: (2000)

A review of the MHC genetics of rheumatoid arthritis.
by: Newton, J, et al.
Published: (2004)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
by: Feldmann, M, et al.
Published: (2011)

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
by: Feldmann, M, et al.
Published: (2001)

The value of a biologics clinic: Adherence to the BSR guidelines for the use of anti-TNF alpha therapy in rheumatoid arthritis
by: MacDougall-Davis, S, et al.
Published: (2008)

Genetic and genomic studies of PADI4 in rheumatoid arthritis.
by: Harney, S, et al.
Published: (2005)

Role of PADI4 in rheumatoid arthritis
by: Harney, S, et al.
Published: (2004)

Genetic epidemiology of rheumatoid arthritis.
by: Harney, S, et al.
Published: (2002)

The association of extended TNF haplotypes and susceptibility to rheumatoid arthritis
by: Newton, J, et al.
Published: (2001)

Challenges in mapping non-HLA-DRB1 major histocompatibility genes in rheumatoid arthritis: comment on the article by Vignal et al.
by: Brown, M, et al.
Published: (2009)

Does bursitis of the forefoot improve in patients with rheumatoid arthritis on anti-TNF-alpha therapy?
by: Bowen, C, et al.
Published: (2007)

Nailfold Videocapillaroscopy in Patients with Rheumatoid Arthritis and Psoriatic Arthropathy on ANTI-TNF-ALPHA Therapy
by: Daniela Anghel, et al.
Published: (2023-06-01)

Development of anti-TNF therapy for rheumatoid arthritis.
by: Feldmann, M
Published: (2002)

Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
by: Feldmann, M, et al.
Published: (1995)

Non-inherited maternal HLA alleles are associated with rheumatoid arthritis.
by: Harney, S, et al.
Published: (2003)

PREDICTING RESPONSES TO ANTI-TNF alpha THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS USING METABOLOMIC ANALYSIS OF URINE
by: Kapoor, SR, et al.
Published: (2012)

MHC class III genes in rheumatoid arthritis and the differential association of HLA-DRB1 alleles with disease
by: Harney, S, et al.
Published: (2005)

Genomic and genetic analysis suggests involvement of MHC class III genes in rheumatoid arthritis
by: Harney, S, et al.
Published: (2005)

NON-INHERITED MATERNAL ANTIGENS INFLUENCE SUSCEPTIBILITY TO RHEUMATOID ARTHRITIS
by: Harney, S, et al.
Published: (2002)

HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis.
by: Harney, S, et al.
Published: (2005)

GOLIMUMAB, A HUMAN TNF-ALPHA mu ONOCLONAL ANTIBODY, IN RHEUMATOID ARTHRITIS PATIENTS PREVIOUSLY TREATED WITH ANTI-TNF-ALPHA AGENTS (GO-AFTER STUDY)
by: Wordsworth, P, et al.
Published: (2009)

TNF alpha--a pivotal role in rheumatoid arthritis?
by: Brennan, F, et al.
Published: (1992)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1995)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (2001)

TNF alpha as a therapeutic target in rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1994)

Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases.
by: Taylor, P
Published: (2001)

Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNF&alpha; blocker failure
by: Kekow J, et al.
Published: (2012-07-01)

Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis
by: Szilárd Póliska, et al.
Published: (2019-04-01)

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
by: Charles, P, et al.
Published: (1999)

Occupational therapy in rheumatoid arthritis: short term prospective study in patients treated with anti-TNF-alpha drugs
by: M. Gentili, et al.
Published: (2011-09-01)

Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNF&alpha; therapy
by: Hubert Marotte, et al.
Published: (2008-08-01)

Pain processing in rheumatoid arthritis patients successfully treated with anti-TNF medication
by: Wordsworth, P, et al.
Published: (2009)

Clinical and experimental pain processing in rheumatoid arthritis patients treated with anti-TNF
by: Wartolowska, K, et al.
Published: (2007)

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.
by: Taylor, P, et al.
Published: (2009)

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.
by: Ding, T, et al.
Published: (2010)